THE MAINTENANCE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN BLOOD SERUM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Keywords:
type 2 diabetes mellitus, cardiovascular complications, fibrinolytic activity, plasminogen activator inhibitor-1Abstract
The maintenance of plasminogen activator inhibitor-1 (PAI-1) in blood serum in patients with type 2 diabetes mellitus of the senior age group with long term of disease and the role of this index in the development of cardiovascular complications were studied. The statistically significant dependence of PAI-1 on arterial hypertension, fibrinogen, triglycerides, very low density lipoproteides, body weight index and insulin resistance was determined.
It was shown, that PAI-1 was a significant additional risk factor in the development of cardiovascular diseases in patients with type 2 diabetes mellitus.
Downloads
Issue
Section
Clinical research
License
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
How to Cite
THE MAINTENANCE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN BLOOD SERUM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. (2015). The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", 13, 100-104. https://periodicals.karazin.ua/medicine/article/view/7089
